Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared a post on X:
“Congratulations Brigida Maiorano and Team for putting light on accurate QoL assessment in patients with prostate cancer receiving new androgen targeting agents GU 2026.”
Other articles about ASCO on OncoDaily.
